BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
+77.51%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$170M
AUM Growth
+$170M
(+24%)
Cap. Flow
-$4.22M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
84.84%
Holding
32
New
4
Increased
11
Reduced
7
Closed
2
Top Buys
| 1 |
AN2 Therapeutics
ANTX
|
$6.15M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$4.12M |
| 3 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$3.54M |
| 4 |
Adverum Biotechnologies
ADVM
|
$2.12M |
| 5 |
Oramed Pharmaceuticals
ORMP
|
$2.04M |
Top Sells
| 1 |
Forte Biosciences
FBRX
|
$9.45M |
| 2 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$7.71M |
| 3 |
Instil Bio
TIL
|
$3.78M |
| 4 |
Athira Pharma
ATHA
|
$2.39M |
| 5 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$2.3M |
Sector Composition
| 1 | Healthcare | 73.51% |
| 2 | Technology | 1.04% |
| 3 | Consumer Discretionary | 0% |
